Akten
NDC 17478-792
Product Information
Akten is a NDA-approved product labeled by Akorn. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 17478-792 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 17478-792?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LIDOCAINE HYDROCHLORIDE ANHYDROUS (UNII: EC2CNF7XFP)
- LIDOCAINE (UNII: 98PI200987) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1009462 - lidocaine HCl 3.5 % Ophthalmic Gel
- RxCUI: 1009462 - lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel
- RxCUI: 1009462 - lidocaine hydrochloride 3.5 % Ophthalmic Gel
- RxCUI: 1011703 - Akten 3.5 % Ophthalmic Gel
- RxCUI: 1011703 - lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel [Akten]
* Please review the full disclaimer at the bottom of this page.